IP Library Granted Patent US 12,528,081
Granted Patent B2
US 12,528,081 · App. 18/071,981 · Granted Jan 20, 2026

Binding assay with no wash steps or moving parts using magnetic beads

Inventors: Herschel Watkins (Woodacre, CA); Kristy McKeating (San Francisco, CA)
Assignee: FITBIT, LLC
B01L3/50273B01L3/502707B01L3/502715B01L3/502753B01L2200/04B01L2200/0605B01L2200/0689B01L2200/12B01L2200/16B01L2300/0663B01L2300/0681B01L2300/0864B01L2300/0887B01L2300/126B01L2400/043G01N33/54326G01N33/54346
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,528,081
App. No.
18/071,981
Granted
Jan 20, 2026
Kind
B2
Abstract

This present disclosure provides devices, systems, and methods for performing point-of-care analysis of a target analyte in a biological fluid via a binding assay. The present disclosure includes a cartridge for collecting the target analyte contained in a fluid sample and performing an assay. The cartridge includes an assay stack having a first separation layer, a second separation layer, and a detection membrane. The cartridge also includes a plurality of first complexes comprising a capture molecule and a magnetic bead and a plurality of second complexes comprising a detection molecule and a detection label. Further, the detection membrane includes a substrate that interacts with the detection label to elicit a quantifiable response in the presence of the target analyte. The quantifiable response corresponds to an amount of detection antibody present in the detection membrane, and the amount of detection antibody present corresponds to an amount of the target analyte present.

Claims (28)

1 . A cartridge for collecting a target analyte contained in a fluid sample and performing an assay on the target analyte, wherein the cartridge comprises:

an assay stack, wherein the assay stack comprises:

a first separation layer;

a plurality of first complexes comprising a capture molecule and a magnetic bead;

a plurality of second complexes comprising a detection molecule and a detection label;

a second separation layer; and

a detection membrane comprising a substrate that interacts with the detection label to elicit a quantifiable response in the presence of the target analyte, wherein the quantifiable response corresponds to an amount of detection molecule present in the detection membrane, and wherein the amount of detection molecule present in the detection membrane corresponds to an amount of the target analyte present in the fluid sample; and

wherein the second separation layer prevents passage of any unbound second complexes of the plurality of second complexes to the detection membrane.

2 . The cartridge according to claim 1 , wherein the second separation layer comprises a hydrophobic membrane, a low molecular weight cut-off membrane, or a combination thereof that allows for a third complex comprising the target analyte bound to: (a) one of the first complexes and (b) one of the second complexes to pass to the detection membrane in the presence of an activated electromagnet.

3 . The cartridge according claim 1 , wherein the second separation layer includes a hydrophilic treatment.

4 . The cartridge according to claim 3 , wherein the hydrophilic treatment is a coating that comprises a surfactant.

5 . The cartridge according to claim 1 , wherein the target analyte is contained within a fluid sample selected from the group consisting of blood, saliva, sweat, urine, lymph, tears, synovial fluid, breast milk, serum, plasma, bile, or a component thereof.

6 . The cartridge according to claim 5 , wherein the fluid sample is blood and the first separation layer is a plasma separation membrane that prevents erythrocytes from contacting the second separation layer.

7 . The cartridge according to claim 1 , wherein the detection label comprises a peroxidase enzyme.

8 . The cartridge according to claim 7 , wherein the substrate comprises a reagent for the peroxidase enzyme.

9 . The cartridge according to claim 1 , wherein the cartridge is configured to perform an assay on the target analyte without any wash steps or moving parts.

10 . The cartridge according to claim 1 , wherein at least one component of the cartridge is compressible, thereby allowing for an uncompressed state and a compressed state of the cartridge.

11 . The cartridge according to claim 1 , further comprising a metering stack configured to receive and distribute the fluid sample containing the target analyte along a channel of the cartridge, wherein the channel has a bottom that comprises a porous or mesh material, further wherein the metering stack includes one or more venting holes in communication with the channel.

12 . The cartridge according to claim 11 , wherein a spacer material is disposed between the metering stack and the assay stack, wherein the spacer material provides a gap between the metering stack and the assay stack that prevents the target analyte from flowing from the metering stack into the assay stack when the cartridge is in the uncompressed state.

13 . The cartridge according to claim 11 , wherein the porous or mesh material permits the target analyte to flow from the metering stack to the assay stack upon compression of the at least one component of the cartridge.

14 . A system for collecting a target analyte contained in a fluid sample and performing an assay on the target analyte, the system comprising:

the cartridge of claim 1 ; and

an electromagnet for pulling a third complex comprising the target analyte bound to one of the first complexes and one of the second complexes through the second separation layer to the detection membrane.

15 . The system according to claim 14 , wherein the second separation layer allows for the third complex comprising the target analyte bound to: (a) one of the first complexes and (b) one of the second complexes to pass to the detection membrane when the electromagnet is activated.

16 . The system according to claim 14 , wherein the second separation layer prevents passage of any unbound second complexes to the detection membrane.

17 . The system according to claim 14 , wherein the system further comprises:

a metering stack configured to receive and distribute the target analyte along a channel of the cartridge, wherein the channel has a bottom that comprises a porous or mesh material and wherein the metering stack includes one or more venting holes in communication with the channel.

18 . The system according to claim 14 , further comprising an assay reader that includes the electromagnet.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2023
From: MCKEATING, KRISTY; WATKINS, HERSCHEL
To: FITBIT, INC.
Reel/Frame 062420/0234 →
CHANGE OF NAME Recorded Jan 19, 2023
From: FITBIT, INC.
To: FITBIT LLC
Reel/Frame 062436/0059 →
Continuity (3)
Continuation 17546565 · Dec 9, 2021
Continuation PCTUS2021041988 · Jul 16, 2021
Related Publication 20230089042A1 · Mar 23, 2023
References Cited (20)
US 4868131A · Hiratsuka · 1989 [cited by applicant]
US 10293340B2 · Mai et al. · 2019 [cited by applicant]
US 11554372B1 · Watkins · 2023 [cited by examiner]
US 20070178521A1 · Sakaino et al. · 2007 [cited by applicant]
US 20100031186A1 · Tseng et al. · 2010 [cited by applicant]
US 20100311186A1 · Gregory et al. · 2010 [cited by applicant]
US 20150241423A1 · Dilleen et al. · 2015 [cited by applicant]
US 20210055289A1 · Johannsen et al. · 2021 [cited by applicant]
JP 2014149172A · 2014 [cited by applicant]
WO WO2018097796 · 2018 [cited by applicant]
WO WO2019074760 · 2019 [cited by applicant]
Afriat et al., “Development of a Point-of-Care Technology for Bacterial Identification in Milk”, Talanta, vol. 219, Nov. 1, 2020, 8 pages. [cited by applicant]
Clotilde et al., “Multiplex Immunoassay: A Planar Array on a Chip Using the MagArray™ Technology”, ELISA: Methods and Protocols, Methods in Molecular Biology, vol. 1318, pp. 119-126. [cited by applicant]
Dutta et al., “Wash-Free, Label-Free Immunoassay for Rapid Electrochemical Detection of Pfhrp2 in Whole Blood Samples”, Scientific Reports, www.nature.com/scientificreports, Nov. 20, 2018, 8 pages. [cited by applicant]
Eltzov et al., “Colorimetric Stack Pad Immunoassay for Bacterial Identification”, Biosensors and Bioelectronics, vol. 87, Jan. 15, 2017, pp. 572-578. [cited by applicant]
Eltzov et al., “Miniaturized Flow Stacked Immunoassay for Detecting Escherichia coli in a Single Step”, Analytical Chemistry, Jun. 21, 2016, vol. 88, No. 12, pp. 6441-6449. [cited by applicant]
Harpaz et al., “Enhanced Colorimetric Signal for Accurate Signal Detection in Paper-Based Biosensors”, Diagnostics 2020, vol. 10, No. 28, 15 pages. [cited by applicant]
Harpaz et al., “Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest”, Biosensors 2017, vol. 7, No. 30, 39 pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2021/041988, mailed Apr. 12, 2022, 17 pages. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/US2021/041988, mailed Jan. 25, 2024, 10 pages. [cited by applicant]